Integration of Genetic Testing and Counseling in Patients With Breast Cancer in a Large, Multisite Community-Based Practice
Mendenhall, Molly A, Guinigundo, Andrew, Davies, Dan, Ward, Patrick, Drosick, David R, Waterhouse, David M
Published in JCO oncology practice (01.02.2024)
Published in JCO oncology practice (01.02.2024)
Get more information
Journal Article
Sustainable Integration of US Food and Drug Administration-Approved Biosimilars: Pharmacy- Versus Physician-Driven Change
Waterhouse, David M, Ward, Patrick, Drosick, David R, Burdette, Caleb, Davies, Daniel, Mendenhall, Molly A
Published in JCO oncology practice (01.11.2023)
Published in JCO oncology practice (01.11.2023)
Get more information
Journal Article
Closing the Testing Gap: Standardization of Comprehensive Biomarker Testing for Metastatic Non-Small-Cell Lung Cancer in a Large Community Oncology Practice
Waterhouse, David M, Ward, Patrick, Arnal, Suzzette, Neubauer, Marcus, Drosick, David R, Davies, Dan, Mendenhall, Molly A
Published in JCO oncology practice (01.06.2023)
Published in JCO oncology practice (01.06.2023)
Get more information
Journal Article
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer
Yardley, Denise A., Arrowsmith, Edward R., Daniel, Brooke R., Eakle, Janice, Brufsky, Adam, Drosick, David R., Kudrik, Fred, Bosserman, Linda D., Keaton, Mark R., Goble, Sharon A., Bubis, Jeffrey A., Priego, Victor M., Pendergrass, Kelly, Manalo, Yvonne, Bury, Martin, Gravenor, Donald S., Rodriguez, Gladys I., Inhorn, Roger C., Young, Robyn R., Harwin, William N., Silver, Caryn, Hainsworth, John D., Burris, Howard A.
Published in Breast cancer research and treatment (01.08.2017)
Published in Breast cancer research and treatment (01.08.2017)
Get full text
Journal Article
Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial
Yardley, Denise A., Dickson, Natalie, Drosick, David, Earwood, Chris, Inhorn, Roger, Murphy, Patrick, Hainsworth, John D.
Published in Clinical breast cancer (01.06.2016)
Published in Clinical breast cancer (01.06.2016)
Get full text
Journal Article
Abstract P3-11-08: Eribulin/cyclophosphamide (ErC) versus docetaxel/cyclophosphamide (TC) as neoadjuvant therapy in locally advanced HER2-negative breast cancer: A randomized phase II trial of the Sarah Cannon Research Institute
Yardley, Denise, Dyehouse, Karyn, Mani, Aruna, Calfa, Carmen, Drosick, David, Yost, Kathleen, Shipley, Diana, Quinn, Raven, Young, Robyn, Finney, Lindsey, Earwood, Chris, Shastry, Mythili, Hainsworth, John
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Get full text
Journal Article
Sorafenib Plus Ixabepilone as First-Line Treatment for Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase 1/2 Trial
Yardley, Denise A., MD, Dickson, Natalie, MD, Drosick, David, MD, Earwood, Chris, Inhorn, Roger, MD, Murphy, Patrick, MD, Hainsworth, John D., MD
Published in Clinical breast cancer (2016)
Published in Clinical breast cancer (2016)
Get full text
Journal Article
A Phase II Trial of Gemcitabine/Carboplatin with or Without Trastuzumab in the First-Line Treatment of Patients with Metastatic Breast Cancer
Yardley, Denise A, Burris, Howard A, Simons, Lisa, Spigel, David R, Greco, F. Anthony, Barton, John H, Shipley, Dianna, Drosick, David, Hainsworth, John D
Published in Clinical breast cancer (01.10.2008)
Published in Clinical breast cancer (01.10.2008)
Get full text
Journal Article